Publications

5891 Results

Image registration for quantitative parametric response mapping of cancer treatment response

Authors
JL Boes;BA Hoff;N Hylton;MD Pickles;LW Turnbull;AF Schott;A Rehemtulla;R Chamberlain;B Lemasson;R Chenevert;CJ Galban;CR Meyer;BD Ross
Journal / Conference
Translational Oncology 7(1):101-110;
Year
2014
Research Committee(s)
Breast
PMID
PMID24772213
PMC
PMC3998680
Study Number(s)
S0800

Prostate Cancer Prevention Trial risk calculator 2.0: for the prediction of low- vs high-grade prostate cancer

Authors
D Ankerst;J Hoefler;S Bock;P Goodman;A Vickers;J Hernandez;LJ Sokoll;M Sanda;J Wei;R Leach;IM Thompson
Journal / Conference
Urology 83(6):1362-1368;
Year
2014
Research Committee(s)
Cancer Control
PMID
PMID24862395
PMC
PMC4035700
Study Number(s)
SWOG-9217

Circulating fatty acids and prostate cancer risk: individual participant meta-analysis of prospective studies

Authors
FL Crowe;P Appleby;R Travis;M Barnett;T Brasky;H Bueno-de-Mesquita;J Chavarro;D English;R Gibson;G Giles;G Goodman;S Henning;R Kaaks;I King;L Kolonel;A Kristal;M Neuhouser;SY Park;G Severi;A Siddiq;D Stampfer;P Stattin;C Tangen;A Tionneland;D Trichopoulos;R Tumino;L Wilkens;T Key
Journal / Conference
Journal of the National Cancer Institute Sep 10;106(9): pii: dju240. Print 2014 Sep.;
Year
2014
Research Committee(s)
Cancer Control, Prevention, Screening, and and Surveillance
PMID
PMID2521020
PMC
PMC4188122
Study Number(s)
S0000, SWOG-9217

Meeting cancer survivors needs: survivors perspective

Authors
E Lackey;K Anderson;A Gottlieb;R Krouse;C Fabian;J Klemp
Journal / Conference
Cancer Survivorship Research Conference (June 18-20, 2014 Atlanta, GA), poster;
Year
2014
Research Committee(s)
Cancer Survivorship

Results of a survivorship needs assessment survey within a large cooperative group (SWOG)

Authors
J Klemp;E Lackey;K Anderson;A Gottlieb;R Krouse;C Fabian
Journal / Conference
Cancer Survivorship Research Conference (June 18-20, 2014 Atlanta, GA), poster;
Year
2014
Research Committee(s)
Cancer Survivorship

Long-term disease control of advanced gastrointestinal stromal tumors (GIST) with imatinib (IM): 10-year outcomes from SWOG phase III intergroup trial S0033

Authors
G Demetri;C Rankin;R Benjamin;E Borden;CW Ryan;D Priebat;WD Tap;M von Mehren;ME Blackstein;M Heinrich;R Maki;C Corless;JA Fletcher;K Owzar;CD Blanke
Journal / Conference
Journal of Clinical Oncology 32:5s (suppl; abstr 10508);ASCO Annual Meeting (May 30-June 3, 2014, Chicago, IL), oral;
Year
2014
Research Committee(s)
Sarcoma
Study Number(s)
S0033

Outcome of male patients and black patients enrolled in SWOG S0221, an intergroup chemotherapy study

Authors
G Budd;W Barlow;HCF Moore;T Hobday;JA Stewart;C Isaacs;M Salim;JK Cho;K Rinn;KS Albain;H Chew;GV Burton;TD Moore;G Srkalovic;B McGregor;LE Flaherty;R Livingston;D Lew;JR Gralow;GN Hortobagyi
Journal / Conference
Journal of Clinical Oncology 32:5s (suppl; abstr 1016); ASCO Annual Meeting (May 30-June 3, 2014, Chicago, IL), poster highlights session;
Year
2014
Research Committee(s)
Breast
Study Number(s)
S0221

Phase III Trial (Prevention of Early Menopause Study [POEMS]-SWOG S0230) of LHRH Analog during Chemotherapy to Reduce Ovarian Failure in Early Stage, Hormone-Receptor Negative Breast Cancer: An International Intergroup Trial of SWOG, IBCSG, ECOG, CALGB (Alliance)

Authors
HCF Moore;JM Unger;K-A Phillips;F Boyle;E Hitre;D Porter;P Francis;L Minasian;R Gelber;LJ Goldstein;HL Gomez Moreno;C Vallejos;AH Partridge;S Dakhil;S Martino;W Barlow;C Fabian;FL Meyskens;GN Hortobagyi;K Albain
Journal / Conference
Journal of Clinical Oncology 32:5s (suppl; abstr LBA505); ASCO Annual Meeting (May 30-June 3, 2014, Chicago, IL), oral;
Year
2014
Research Committee(s)
Breast
Study Number(s)
S0230

SWOG S0307 phase III trial of bisphosphonates as adjuvant therapy in primary breast cancer: Comparison of toxicities and patient-stated preference for oral versus intravenous delivery (ClinicalTrials.gov Identifier: NCT00127205)

Authors
JR Gralow;WE Barlow;A Paterson;D Lew;A Stopeck;DF Hayes;DL Hershman;M Schubert;M Clemons;CH Van Poznak;BE Dees;JN Ingle;C Falkson;AD Elias;M Messino;JH Margolis;S Dakhil;H Chew;R Livingston;G Hortobagyi
Journal / Conference
Journal of Clinical Oncology 32:5s (suppl; abstr 558); ASCO Annual Meeting (May 30-June 3, 2014, Chicago, IL), general poster session;
Year
2014
Research Committee(s)
Breast
Study Number(s)
S0307

SWOG S0809: A phase II trial of adjuvant capecitabine (cap)/gemcitabine (gem) followed by concurrent capecitabine and radiotherapy in extrahepatic cholangiocarcinoma (EHCC) and gallbladder carcinoma (GBCA)

Authors
E Ben-Josef;K Guthrie;AB El-Khoueiry;CL Corless;MM Zalupski;A Lowy;CR Thomas;SR Alberts;LE Dawson;KC Micetich;MB Thomas;A Siegel;CD Blanke
Journal / Conference
Journal of Clinical Oncology 32:5s (suppl; abstr 4030);ASCO Annual Meeting (May 30-June 3, 2014, Chicago, IL), poster highlights session;
Year
2014
Research Committee(s)
Gastrointestinal
Study Number(s)
S0809